These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 806854)

  • 21. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
    Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experiences with hexobendine in coronary disease].
    Eral N
    Arzneimittelforschung; 1968 Aug; 18(8):1094-103. PubMed ID: 5755844
    [No Abstract]   [Full Text] [Related]  

  • 23. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR; Williams JG; Currier RD
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 25. [Internal medical angiological treatment].
    Thiele P; Heidelmann G
    Z Gesamte Inn Med; 1969 Feb; 24(4):116-9. PubMed ID: 5796654
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies of the administration of ustimon and instenon in cerebrovascular diseases].
    Pichler E; Strauss A
    Wien Klin Wochenschr; 1968 Jan; 80(4):61-4 passim. PubMed ID: 5667714
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P; Martinelli M; De Gregorio M
    Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract]   [Full Text] [Related]  

  • 31. [Control of cerebral blood circulation time during long-term Wallerox therapy. Measurements using external scintillation counters].
    Herzfeld U; Erbe H
    Med Welt; 1971 Nov; 48(71):1933-5. PubMed ID: 5002422
    [No Abstract]   [Full Text] [Related]  

  • 32. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 33. [Alpha blocking properties of dihydro ergot derivatives. Findings on skin and muscle temperature].
    D'Ayala Valva G; Dabizzi RP; Banchelli A
    Riv Crit Clin Med; 1967 Aug; 67(3):191-9. PubMed ID: 4395433
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC
    Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sympatholytic vasodilator in cerebral circulation disorders].
    Lipke PR
    Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the behavior of cerebrovascular resistance under the influence of sympatholytics].
    Klein K; Siedek H
    Wien Med Wochenschr; 1966 Jan; 116(1):20-2. PubMed ID: 4962461
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 38. [Angiographic study of the action of pervincamine on cerebral circulation].
    Baiano G; Elefante R; Granata F; Graziussi G
    Acta Neurol (Napoli); 1974 Mar; 29(2):185-9. PubMed ID: 4848048
    [No Abstract]   [Full Text] [Related]  

  • 39. [Physiotherapeutic management of peripheral arterial blood circulation disorders].
    Grossmann D
    Med Klin; 1967 Aug; 62(32):1240-3. PubMed ID: 5593002
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical observations on the combination citrogenase-aminoxidase-tyrosine (Vasolastine)].
    de Oliveira JM
    Hospital (Rio J); 1968 Sep; 74(3):751-4. PubMed ID: 4986696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.